Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Qscreen AI Inc (OP:PMEDF)

0.0433 UNCHANGED
Streaming Delayed Price Updated: 1:14 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Qscreen AI Inc

< Previous 1 2 3 Next >
News headline image
Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare Operations
Via ACCESSWIRE
News headline image
Predictmedix’s Safe Entry Receives International Recognition in Major Indonesian Newspaper for its Healthcare Application
Via ACCESSWIRE
News headline image
Predictmedix Expands on Non-Invasive AI-powered Impairment Detection Technology for Vertical-Specific Applications
Via ACCESSWIRE
News headline image
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
Via ACCESSWIRE
News headline image
Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
Via ACCESSWIRE
News headline image
Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
Via ACCESSWIRE
News headline image
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia
Via ACCESSWIRE
News headline image
Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector
Via ACCESSWIRE
News headline image
Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare
Via ACCESSWIRE
News headline image
Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange
Via ACCESSWIRE
News headline image
Predictmedix Provides Corporate Update on Key Technology Milestones and Commercialization Outlook for 2023
Via ACCESSWIRE
News headline image
Predictmedix Provides Business and Technology Development Updates and Closes Final Tranche of Private Placement
Via ACCESSWIRE
News headline image
Predictmedix Closes First Tranche of Private Placement
Via ACCESSWIRE
News headline image
Predictmedix and Partners Launch Safe Entry Station as a Comprehensive Fit for Duty Screening Solution at Electra Mining Africa and National Safety Council's (NSC) Congress & Expo
Via ACCESSWIRE
News headline image
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
TORONTO, ON / ACCESSWIRE / July 25, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
News headline image
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
Via ACCESSWIRE
News headline image
Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies
TORONTO, ON / ACCESSWIRE / June 29, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Cannabis
News headline image
EXCLUSIVE: Predictmedix Receives $1.85M LOI For 80 Safe Entry Stations From KaTron Defence Space And Simulation Technologies ↗
Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI) has received a non-binding Letter of Intent 
Via Benzinga
News headline image
Emerging Technologies Are Advancing The Urgent Need For Noninvasive Cannabis Impairment Detection ↗
By Dr. Rahul Kushwah, Interim CEO, Predictmedix 
Via Benzinga
News headline image
Predictmedix Secures Deployment of Safe Entry Stations at De Beers Forevermark Forum 2022
High Visibility, Revenue Generating Deployment Provides Predictmedix with Strong Industry Validation 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
News headline image
Predictmedix Reports Fiscal 2022 Financial Results
TORONTO, ON / ACCESSWIRE / June 1, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Cannabis
News headline image
Predictmedix to Present at 12th Annual LD Micro Invitational
Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
News headline image
Predictmedix Showcases Safe Entry Station Technology at Major Las Vegas Entertainment Event
Placement at Major Las Vegas Venue Served as Live, High-Profile Demonstration of Safe Entry Station to Area Entertainment and Hospitality Sector Representatives TORONTO, ON / ACCESSWIRE / April 5, 2022... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
News headline image
Predictmedix Inc. Issues Shareholder Letter and Provides Corporate Update on Key Milestone Achievements
TORONTO, ON / ACCESSWIRE / February 10, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
News headline image
Predictmedix To Launch Infectious Diseases Clinical Trial in North American Hospital for FDA Medical Device Classification of Safe Entry Stations
Independent Study for Infectious Diseases Symptom Detection in a Clinical Setting to Provide Additional Third-Party Validation; Prerequisite Ahead of Planned FDA Certification as Class II Medical... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
News headline image
Predictmedix Announces Accuracy Rates for Alcohol and Cannabis Impairment Detection Technology and Provides Update on the Next Steps for Technology Commercialization
Upcoming Clinical trial in North American Hospital Expected to Provide Additional Third-Party Validation Ahead of Planned Commercial Launch TORONTO, ON / ACCESSWIRE / January 12, 2022 / Predictmedix... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Cannabis
News headline image
Predictmedix Secures Inaugural Placement of Safe Entry Station at Health and Wellness Retreat in Ontario, Canada
Ste. Anne's Spa, an Ontario-Based Health and Wellness Retreat, to Rollout Safe Entry Station Solution to Ensure Safe Environment for Staff & Guests Health Retreat & Resort Market Represents Significant... 
From Predictmedix
Via AccessWire
News headline image
Predictmedix Launches ThuraPass Safe Entry Program for Sports and Entertainment Industry in Conjunction with Uptown Sports Marketing
First Major Deployment at Formula One United States Grand Prix Successfully Identified COVID-19 Infected Staff Prior to Event Entry TORONTO, ON / ACCESSWIRE / November 3, 2021 / Predictmedix Inc.... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Intellectual Property
News headline image
Predictmedix Safe Entry Station Receives CE Mark Approval and ISO Certification for Commercialization in the European Union
Regulatory Approval Enables Commercialization in New, Leading Global Marketplaces TORONTO, ON / ACCESSWIRE / November 2, 2021 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Intellectual Property
News headline image
Predictmedix Deployed Safe Entry Stations at Formula 1 Aramco United States Grand Prix
Company Deployed 15 Safe Entry Stations at Circuit of the Americas in Austin, Texas to Screen Hospitality Suite Attendees and Catering Staff TORONTO, ON / ACCESSWIRE / October 25, 2021 / Predictmedix... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Intellectual Property
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.